Collecting data on head and neck cancer patients' characteristics and outcomes
Official title: The Clinical, Epidemiological and Treatment Characteristics of Head and Neck Cancer Patients Presenting to Different Levels of the Health Care System
Run by University of Pecs · NCT05319483 · Data updated 2026-11-12
This study is trying to gather information about head and neck cancer patients, including their backgrounds and health outcomes, to see what factors might affect their treatment and survival.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Pecs Academic / other |
| Locations | 1 site (Pécs, Baranya) |
| Status | Recruiting |
| Started | October 1, 2021 |
| Main results expected | October 1, 2024 |
| Study ends | October 1, 2029 |
| Registry record updated | April 8, 2022 |
| Trial ID | NCT05319483 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and over who are newly diagnosed with head and neck cancer, specifically squamous cell carcinoma.
✕Probably not a fit
Patients with recurrent head and neck cancer or those who do not meet the inclusion criteria will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to prospectively gather information on the demographic, lifestyle-related, and clinical characteristics of patients diagnosed with head and neck cancer. It will also assess waiting times for diagnosis and treatment, as well as the survival rates at 1, 3, and 5 years. Data will be collected through patient interviews and electronic medical records, focusing on factors such as initial symptoms, lifestyle habits, and disease progression. The goal is to identify factors that influence patient outcomes and potentially improve treatment pathways.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding of head and neck cancer outcomes and inform strategies to enhance patient care.
How similar studies have gone: While similar studies have explored patient pathways and outcomes in cancer, this specific approach focusing on head and neck cancer characteristics is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18 years or over presenting with head and neck cancer (with morphology of squamocellular carcinoma), who are subsequently given one of the following ICD-10 codes: Malignant neoplasms of lip, oral cavity and pharynx (C00-C14), Malignant neoplasm of larynx (C32) and for whom this is their first cancer. Exclusion Criteria: * Patients who do not meet the inclusion criteria and patients who meet the inclusion criteria but for whom this is a second or recurrent cancer (they already have an "ICD-C" code) are excluded from the study
Where it's running
-
University of Pécs, Clinical Centre
Pécs, Baranya, Hungary Recruiting
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.